Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study
Drug Safety · 2026-09 · 49 (9) · 1085-1097
DOI: 10.1007/s40264-026-01672-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety, online erschienen am 02.06.2026. Verfasst von Anna-Belle Beau und 21 weiteren Autor:innen. Beteiligte Einrichtung: CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3…. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Pregabalin, Gabapentin. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines Initiative, Université de Toulouse.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France. anna-belle.beau@univ-tlse3.fr.
- CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France.
- Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
- Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
- Unit of Epidemiology of Rare Diseases and Congenital Anomalies. Institute of Clinical Physiology, National Research Council, Pisa, Italy.
- School of Medicine, Ulster University, Belfast, United Kingdom.
Förderung
- Innovative Medicines Initiative
- Université de Toulouse
Zitieren
APA
Beau, A. B., Castro, E. C., Benevent, J., Beslay, M., Barrachina-Bonet, L., Bergman, J. E. H., Cavero-Carbonell, C., Coi, A., Dolk, H., Garne, E., Gatt, M., Hoareau, J., Hond, E. D., Latos-Bielenska, A., Lelong, N., O'Mahony, M., Moisset, X., Morris, J., Neville, A. J., …, & Damase-Michel, C. (2026). Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. Drug Safety, 49(9), 1085-1097. https://doi.org/10.1007/s40264-026-01672-8
Vancouver
Beau AB, Castro EC, Benevent J, Beslay M, Barrachina-Bonet L, Bergman JEH, et al. Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. Drug Safety. 2026;49(9):1085-1097. doi:10.1007/s40264-026-01672-8
BibTeX
@article{Beau2026,
author = {Beau, Anna-Belle and Castro, Erika Cifuentes and Benevent, Justine and Beslay, Marie and Barrachina-Bonet, Laia and Bergman, Jorieke E H and Cavero-Carbonell, Clara and Coi, Alessio and Dolk, Helen and Garne, Ester and Gatt, Miriam and Hoareau, Jonathan and Hond, Elly Den and Latos-Bielenska, Anna and Lelong, Nathalie and O'Mahony, Mary and Moisset, Xavier and Morris, Joan and Neville, Amanda J and Sichitiu, Joanna and Loane, Maria and Damase-Michel, Christine},
title = {Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study},
journal = {Drug Safety},
year = {2026},
volume = {49},
number = {9},
pages = {1085--1097},
doi = {10.1007/s40264-026-01672-8}
}
EUVIMED